Clinical Laserthermia Systems AB (publ) (CLS-B) — Working Capital to Net Assets Ratio
Clinical Laserthermia Systems AB (publ) (CLS-B) has a Working Capital to Net Assets ratio of -3.6% as of June 2026. Working capital of Skr-1.59 Million (current assets of Skr23.86 Million minus current liabilities of Skr25.45 Million) is measured against net assets of Skr44.50 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See CLS-B days of operational coverage to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Clinical Laserthermia Systems AB (publ) Working Capital to Net Assets (2008–2025)
This chart shows how Clinical Laserthermia Systems AB (publ)'s Working Capital to Net Assets ratio has evolved across 18 annual periods from 2008 to 2025. As of June 2026, the ratio stands at -3.6%, reflecting working capital of Skr-1.59 Million against net assets of Skr44.50 Million SEK. For the complete balance sheet picture, see total assets of Clinical Laserthermia Systems AB (publ).
Annual Working Capital to Net Assets for Clinical Laserthermia Systems AB (publ) (2008–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Clinical Laserthermia Systems AB (publ) from 2008 to 2025, covering 18 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Clinical Laserthermia Systems AB (publ) (CLS-B) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 43.8% | Skr29.12 Million | Skr66.48 Million | Skr39.12 Million | Skr10.00 Million | ▲ +4.9 pp |
| 2024 | 38.9% | Skr25.54 Million | Skr65.69 Million | Skr38.41 Million | Skr12.87 Million | ▲ +8.6 pp |
| 2023 | 30.3% | Skr13.17 Million | Skr43.53 Million | Skr27.14 Million | Skr13.97 Million | ▲ +251.2 pp |
| 2022 | -220.9% | Skr-17.38 Million | Skr7.87 Million | Skr24.26 Million | Skr41.64 Million | ▼ -206.6 pp |
| 2021 | -14.3% | Skr-3.03 Million | Skr21.18 Million | Skr42.42 Million | Skr45.45 Million | ▲ +51.3 pp |
| 2020 | -65.6% | Skr-9.13 Million | Skr13.93 Million | Skr20.90 Million | Skr30.03 Million | ▲ +199.0 pp |
| 2019 | -264.6% | Skr-18.51 Million | Skr7.00 Million | Skr12.55 Million | Skr31.06 Million | ▼ -313.0 pp |
| 2018 | 48.4% | Skr24.09 Million | Skr49.81 Million | Skr31.30 Million | Skr7.21 Million | ▲ +18.5 pp |
| 2017 | 29.9% | Skr9.85 Million | Skr33.00 Million | Skr20.40 Million | Skr10.54 Million | ▲ +47.3 pp |
| 2016 | -17.5% | Skr-2.98 Million | Skr17.06 Million | Skr7.26 Million | Skr10.24 Million | ▼ -22.1 pp |
| 2015 | 4.6% | Skr901.59K | Skr19.46 Million | Skr3.71 Million | Skr2.81 Million | ▼ -42.4 pp |
| 2014 | 47.1% | Skr14.86 Million | Skr31.58 Million | Skr20.24 Million | Skr5.38 Million | ▲ +1.8 pp |
| 2013 | 45.3% | Skr11.81 Million | Skr26.09 Million | Skr14.84 Million | Skr3.04 Million | ▲ +15.2 pp |
| 2012 | 30.1% | Skr5.14 Million | Skr17.09 Million | Skr8.04 Million | Skr2.89 Million | ▲ +21.9 pp |
| 2011 | 8.2% | Skr890.04K | Skr10.83 Million | Skr2.92 Million | Skr2.03 Million | ▼ -13.0 pp |
| 2010 | 21.2% | Skr2.19 Million | Skr10.36 Million | Skr3.39 Million | Skr1.20 Million | ▲ +11.1 pp |
| 2009 | 10.1% | Skr667.09K | Skr6.63 Million | Skr1.65 Million | Skr983.65K | ▼ -22.1 pp |
| 2008 | 32.2% | Skr1.18 Million | Skr3.68 Million | Skr2.23 Million | Skr1.05 Million | — |